Dyskinesias  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dyskinesias
NCT01233856: Omega-3 Fatty Acids as an Adjunctive Therapy for Treatment in Attention-Deficit Hyperactivity Disorder (ADHD)

Recruiting
N/A
30
US
Lovaza, Placebo (corn oil).
Maimonides Medical Center, GlaxoSmithKline
Attention-Deficit/Hyperactivity Disorder
06/12
06/12
NCT02704455: Registry Study on Primary Ciliary Dyskinesia in Chinese Children

Not yet recruiting
N/A
100
RoW
Beijing Children's Hospital, Shengjing Hospital, Capital Institute of Pediatrics, China, Shanghai Children's Medical Center, Shenzhen Children's Hospital, The First Affiliated Hospital of Xiamen University, First Affiliated Hospital of Guangxi Medical University
Primary Ciliary Dyskinesia
05/30
07/30
SPORTAX-NHS, NCT02701036: Sporadic Degenerative Ataxia With Adult Onset: Natural History Study

Recruiting
N/A
300
Europe
Ataxia Study Group, German Center for Neurodegenerative Diseases (DZNE)
Late Onset Sporadic Cerebellar Ataxia
12/30
12/30
EUROSCA-NHS, NCT02440763: The EUROSCA Natural History Study

Recruiting
N/A
400
Europe
Ataxia Study Group
Spinocerebellar Ataxia
07/50
07/50

Download Options